245 related articles for article (PubMed ID: 26937231)
1. Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside.
Ahmed MS; Bae YS
Immune Netw; 2016 Feb; 16(1):44-51. PubMed ID: 26937231
[TBL] [Abstract][Full Text] [Related]
2. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
[TBL] [Abstract][Full Text] [Related]
3. Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4
Jansen MAA; Spiering R; Ludwig IS; van Eden W; Hilkens CMU; Broere F
Front Immunol; 2019; 10():2068. PubMed ID: 31555285
[TBL] [Abstract][Full Text] [Related]
4. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
Hilkens CM; Isaacs JD
Clin Exp Immunol; 2013 May; 172(2):148-57. PubMed ID: 23574312
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
Harry RA; Anderson AE; Isaacs JD; Hilkens CM
Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis.
Ning B; Wei J; Zhang A; Gong W; Fu J; Jia T; Yang SY
PLoS One; 2015; 10(6):e0131152. PubMed ID: 26107250
[TBL] [Abstract][Full Text] [Related]
7. Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.
Obregon C; Kumar R; Pascual MA; Vassalli G; Golshayan D
Front Immunol; 2017; 8():1514. PubMed ID: 29250057
[TBL] [Abstract][Full Text] [Related]
8. Reestablish immune tolerance in rheumatoid arthritis.
Shuai Z; Zheng S; Wang K; Wang J; Leung PSC; Xu B
Front Immunol; 2022; 13():1012868. PubMed ID: 36248797
[TBL] [Abstract][Full Text] [Related]
9. Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration.
Mansilla MJ; Hilkens CMU; Martínez-Cáceres EM
Immunother Adv; 2023; 3(1):ltad012. PubMed ID: 37546348
[TBL] [Abstract][Full Text] [Related]
10. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide-induced tolerogenic dendritic cells attenuated arthritis in experimental collagen-induced arthritic mice.
Wu H; Shen J; Liu L; Lu X; Xue J
Int J Rheum Dis; 2019 Jul; 22(7):1255-1262. PubMed ID: 31062502
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
[TBL] [Abstract][Full Text] [Related]
13. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?
Stoop JN; Robinson JH; Hilkens CM
Ann Rheum Dis; 2011 Sep; 70(9):1526-33. PubMed ID: 21804099
[TBL] [Abstract][Full Text] [Related]
14. Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.
Kim SH; Jung HH; Lee CK
Yonsei Med J; 2018 Sep; 59(7):807-815. PubMed ID: 30091313
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?
Van Brussel I; Lee WP; Rombouts M; Nuyts AH; Heylen M; De Winter BY; Cools N; Schrijvers DM
Autoimmun Rev; 2014 Feb; 13(2):138-50. PubMed ID: 24120737
[TBL] [Abstract][Full Text] [Related]
16. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
[TBL] [Abstract][Full Text] [Related]
17. Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications.
Yoo S; Ha SJ
Immune Netw; 2016 Feb; 16(1):52-60. PubMed ID: 26937232
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening identification of novel immunomodulatory combinations for the generation of tolerogenic dendritic cells.
Jia S; Kim J; Esser-Kahn AP; Deak P
Front Med (Lausanne); 2023; 10():1298424. PubMed ID: 38249971
[TBL] [Abstract][Full Text] [Related]
19. Development and Functional Characterization of Murine Tolerogenic Dendritic Cells.
Wei HJ; Letterio JJ; Pareek TK
J Vis Exp; 2018 May; (135):. PubMed ID: 29863666
[TBL] [Abstract][Full Text] [Related]
20. Tolerogenic Dendritic Cells Generated by BAFF Silencing Ameliorate Collagen-Induced Arthritis by Modulating the Th17/Regulatory T Cell Balance.
Zhao Y; Sun X; Yang X; Zhang B; Li S; Han P; Zhang B; Wang X; Li S; Chang Y; Wei W
J Immunol; 2020 Feb; 204(3):518-530. PubMed ID: 31843958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
